Krystal Biotech Inc (NASDAQ:KRYS)
| 111.40 Delayed Data As of Oct 02 |  -4.60 / -3.97%Today’s Change | 61.11 Today|||52-Week Range 132.68 | +40.62% Year-to-Date |
Latest KRYS News | Press Releases
No recent news for Krystal Biotech Inc.
Today’s Trading
| Previous close | 116.00 |
| Today’s open | 114.75 |
| Day’s range | 111.19 - 115.62 |
| Volume | 10,526 |
| Average volume (3 months) | 290,039 |
| Market cap | $3.3B |
Data as of 3:59pm ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | -75.20% |
| Earnings growth (this year) | +9.29% |
| Earnings growth (next 5 years) | -22.67% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INDVIndivior PLC | -1.26 | -5.46% |
| ---- | ||
| ACADACADIA Pharmaceutica... | +0.63 | +3.02% |
| ---- |
Data as of 4:00pm ET, 10/02/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$1.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$140.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pittsburgh, Pennsylvania |
Forecasts
